| Bioactivity | Ulefnersen sodium is a RNA-binding protein fused-in sarcoma (FUS) synthesis reducer[1]. Ulefnersen sodium can be used in Amyotrophic Lateral Sclerosis (ALS) research[2]. |
| CAS | 2589926-27-0 |
| Formula | C230H302N68O126P19S13Na19 |
| Molar Mass | 7477.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P, Shneider NA. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat Med. 2022;28(1):104-116. |
Ulefnersen sodium
CAS: 2589926-27-0 F: C230H302N68O126P19S13Na19 W: 7477.40
Ulefnersen sodium is a RNA-binding protein fused-in sarcoma (FUS) synthesis reducer. Ulefnersen sodium can be used in Am
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.